Related Experiment Videos
[Perioperative risk reduction in vascular surgery via cardio-protective medication]
H H H Feringa1, J J Bax, D Poldermans
1Afd. Cardiologie, Erasmus MC-Centrum, Dr.Molewaterplein 40, 3015 GD Rotterdam.
Insights
Identifying patients with coronary artery disease before noncardiac surgery is crucial. Beta-blockers effectively reduce perioperative cardiovascular risk, with optimal dosage and continuation post-discharge being key factors.
Area of Science:
- Cardiology
- Perioperative Medicine
- Vascular Surgery
Context:
- Cardiovascular complications are the primary cause of mortality following noncardiac surgery.
- Preoperative identification and management of coronary artery disease are essential for mitigating surgical risks.
Purpose:
- To review current strategies for preoperative risk stratification and management of patients undergoing noncardiac surgery.
- To highlight the role of natriuretic peptides as a novel risk marker and beta-blockers in reducing perioperative cardiovascular events.
Summary:
- Preoperative risk stratification models aid in identifying patients at high, intermediate, or low risk.
- Natriuretic peptide concentration is a promising new marker for preoperative risk assessment.
- Beta-blockers significantly reduce perioperative risk, emphasizing adequate dosage, heart rate control, and post-discharge continuation.
Impact:
- Optimized perioperative medical management, including beta-blocker therapy, can improve both short-term and long-term outcomes.
- Further research into statins' perioperative cardioprotective effects is warranted before routine recommendation.
- Improved patient selection and targeted interventions can reduce mortality after noncardiac surgery.
Abstract:
Cardiovascular complications are the leading cause of death after noncardiac surgery. Preoperative identification of patients with underlying coronary artery disease is important, and appropriate treatment strategies should be implemented in these patients in order to reduce the risk of perioperative complications. Based on recent findings, preoperative risk stratification models have been developed to identify high-, intermediate- or low-risk patients; the concentration of natriuretic peptides is a promising new preoperative risk marker. beta-blockers considerably reduce this risk. In clinical practice, important factors are adequate beta-blocker dosage, tight perioperative heart-rate control and continuation of beta-blockers after discharge. Recently, statins have emerged as drugs with perioperative cardioprotective properties, but more randomized clinical trials are needed before routine administration ofstatins can be recommended. Perioperative medical management should focus on improvements not only in the short-term but also in the long-term.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Aneurysm IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care